(Q38307029)

2 September 2017

1 reference

title

Calcineurin inhibitor-sparing regimens based on mycophenolic acid after kidney transplantation (English)

1 reference

2 September 2017

kidney transplantation

1 reference

4

Lionel Rostaing

1 reference

2 September 2017

1

Nassim Kamar

1 reference

2 September 2017

2

Arnaud Del Bello

1 reference

2 September 2017

3

Julie Belliere

1 reference

2 September 2017

29 January 2015

1 reference

2 September 2017

Transplant International

1 reference

2 September 2017

28

1 reference

2 September 2017

8

1 reference

2 September 2017

928-937

1 reference

Immunosuppressive drugs for kidney transplantation.

2 September 2017

1 reference

Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus

21 January 2018

1 reference

Strategies to improve long-term outcomes after renal transplantation

21 January 2018

1 reference

Identifying specific causes of kidney allograft loss.

21 January 2018

1 reference

The natural history of chronic allograft nephropathy

21 January 2018

1 reference

Chronic renal failure after transplantation of a nonrenal organ

21 January 2018

1 reference

Belatacept-based immunosuppression in de novo liver transplant recipients: 1-year experience from a phase II randomized study

21 January 2018

1 reference

Immunosuppressive minimization with mTOR inhibitors and belatacept.

21 January 2018

1 reference

Chronic allograft nephropathy: prospective randomised trial of cyclosporin withdrawal and mycophenolate mofetil or tacrolimus substitution

21 January 2018

1 reference

Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy

21 January 2018

1 reference

Late calcineurin inhibitor withdrawal as a strategy to prevent graft loss in patients with suboptimal kidney transplant function

21 January 2018

1 reference

Withdrawal of cyclosporine or tacrolimus after addition of mycophenolate mofetil in patients with chronic allograft nephropathy

21 January 2018

1 reference

Mycophenolate mofetil substitution for cyclosporine a in renal transplant recipients with chronic progressive allograft dysfunction: the "creeping creatinine" study

21 January 2018

1 reference

A randomized controlled trial of immunosuppression conversion for the treatment of chronic allograft nephropathy

21 January 2018

1 reference

Impact of cyclosporine reduction with MMF: a randomized trial in chronic allograft dysfunction. The 'reference' study

21 January 2018

1 reference

Long-Term Impact of Cyclosporin Reduction with MMF Treatment in Chronic Allograft Dysfunction: REFERENECE Study 3-Year Follow Up

21 January 2018

1 reference

Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen in stable kidney transplant recipients: a randomized, controlled study.

21 January 2018

1 reference

Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen: results of a five-year, prospective, randomized study

21 January 2018

1 reference

Low-dose mycophenolate mofetil is an effective and safe treatment to permit phased reduction in calcineurin inhibitors in chronic allograft nephropathy

21 January 2018

1 reference

A prospective, randomized clinical trial of cyclosporine reduction in stable patients greater than 12 months after renal transplantation

21 January 2018

1 reference

A 50% reduction in cyclosporine exposure in stable renal transplant recipients: renal function benefits

21 January 2018

1 reference

Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation

21 January 2018

1 reference

A calcineurin antagonist-free induction/maintenance strategy for immunosuppression in elderly recipients of renal allografts from elderly cadaver donors: long-term results from a prospective single centre trial

21 January 2018

1 reference

Calcineurin-inhibitor avoidance in elderly renal allograft recipients using ATG and basiliximab combined with mycophenolate mofetil

21 January 2018

1 reference

Predictive factors of acute rejection after early cyclosporine withdrawal in renal transplant recipients who receive mycophenolate mofetil: results from a prospective, randomized trial.

21 January 2018

1 reference

Reduced exposure to calcineurin inhibitors in renal transplantation

21 January 2018

1 reference

The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudy

21 January 2018

1 reference

Acute rejection in low-toxicity regimens: clinical impact and risk factors in the Symphony study

21 January 2018

1 reference

Calcineurin inhibitor minimization in the Symphony study: observational results 3 years after transplantation.

21 January 2018

1 reference

Calcineurin inhibitor sparing with mycophenolate in kidney transplantation: a systematic review and meta-analysis.

21 January 2018

1 reference

Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/TRI.12515

1 reference

2 September 2017

1 reference

PubMed ID

25557802